1. Antiproliferative activity of new derivatives of pyrazino[1, 2‐a]benzimidazole: Integrated cell‐based assay and computational studies with divalent magnesium, iron, and copper ions. Issue 10 (6th July 2022) Authors: Rahimifard, Mahban; Jalalimanesh, Nafiseh; Movahed, Mahsa A.; Hadjighassem, Mahmoudreza; Pourahmad Jaktaji, Razieh; Bagheri, Zeinab; Pourahmad, Jalal; Zarghi, Afshin Journal: Journal of biochemical and molecular toxicology Issue: Volume 36:Issue 10(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Attenuation of Inflammatory Responses in Breast and Ovarian Cancer Cells by a Novel Chalcone Derivative and Its Increased Potency by Curcumin. (12th January 2023) Authors: Nourbakhsh, Mitra; Noori, Shokoofe; Aminzade, Zahra; Bayanati, Maryam; Alemi, Mehrdad; Zarghi, Afshin Other Names: Rai Sachchida Nand Academic Editor. Journal: Mediators of inflammation Issue: Volume 2023(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Design, synthesis and biological evaluation of 7-(aryl)-2, 3-dihydro-[1, 4]dioxino[2, 3-g]quinoline derivatives as potential Hsp90 inhibitors and anticancer agents. Issue 3 (1st February 2017) Authors: Malayeri, Sina Omid; Abnous, Khalil; Arab, Atefeh; Akaberi, Maryam; Mehri, Soghra; Zarghi, Afshin; Ghodsi, Razieh Journal: Bioorganic & medicinal chemistry Issue: Volume 25:Issue 3(2017) Page Start: 1294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents. (15th February 2021) Authors: Abolhasani, Hoda; Zarghi, Afshin; Komeili Movahhed, Tahereh; Abolhasani, Ahmad; Daraei, Bahram; Dastmalchi, Siavoush Journal: Bioorganic & medicinal chemistry Issue: Volume 32(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Design, synthesis, and biological evaluation of new 1, 4‐diarylazetidin‐2‐one derivatives (β‐lactams) as selective cyclooxygenase‐2 inhibitors. Issue 3 (9th January 2020) Authors: Arefi, Hadi; Naderi, Nima; Shemirani, Amir B. Irani; Kiani Falavarjani, Mina; Azami Movahed, Mahsa; Zarghi, Afshin Journal: Archiv der Pharmazie Issue: Volume 353:Issue 3(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Design, Synthesis, and Biological Evaluation of New Peptide Analogues as Selective COX‐2 Inhibitors. Issue 10 (5th September 2017) Authors: Ahmaditaba, Mohammad A.; Shahosseini, Soraya; Daraei, Bahram; Zarghi, Afshin; Houshdar Tehrani, Mohammad H. Journal: Archiv der Pharmazie Issue: Volume 350:Issue 10(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Design, synthesis, and biological evaluation of new pyrazino[1, 2‐a]benzimidazole derivatives as selective cyclooxygenase (COX‐2) inhibitors. Issue 2 (18th December 2018) Authors: Azami Movahed, Mahsa; Daraei, Bahram; Shahosseini, Soraya; Esfahanizadeh, Marjan; Zarghi, Afshin Journal: Archiv der Pharmazie Issue: Volume 352:Issue 2(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors. Issue 11 (24th July 2019) Authors: Dowlati Beirami, Amirreza; Hajimahdi, Zahra; Zarghi, Afshin Journal: Journal of biomolecular structure & dynamics Issue: Volume 37:Issue 11(2019) Page Start: 2999 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Evaluation of Cytotoxic Potentials of Novel Cyclooxygenase-2 Inhibitor against ALL Lymphocytes and Normal Lymphocytes and Its Anticancer Effect through Mitochondrial Pathway. (20th October 2020) Authors: Salimi, Ahmad; Aghvami, Marjan; Azami Movahed, Mahsa; Zarei, Mohammad Hadi; Eshghi, Peyman; Zarghi, Afshin; Pourahmad, Jalal Journal: Cancer investigation Issue: Volume 38:Number 8/9(2020) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluation of Cytotoxic Potentials of Novel Cyclooxygenase-2 Inhibitor against ALL Lymphocytes and Normal Lymphocytes and Its Anticancer Effect through Mitochondrial Pathway. (20th October 2020) Authors: Salimi, Ahmad; Aghvami, Marjan; Azami Movahed, Mahsa; Zarei, Mohammad Hadi; Eshghi, Peyman; Zarghi, Afshin; Pourahmad, Jalal Journal: Cancer investigation Issue: Volume 38:Number 8/9(2020) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗